Eli Lilly is suing pharmacies and peptide vendors over sale of its next big weight-loss drug: retatrutide
Some Americans have turned to medical spas and pharmacies that sell peptides for health and wellness benefits for access to compounded versions of retatrutide.
This is a summary. Read the complete story at MarketWatch below.
Read full article at MarketWatchRelated Stories
U.S. inflation rises again and keeps the pressure on Fed
The main inflation gauge used by the Federal Reserve to set U.S. interest rates rose sharply in August, underscoring why the central bank raised interest rates earlier this month for the first time in three years.
MarketWatch
Meta is pitching a bold new identity — and the payoff could be big
Enterprise tools present a compelling business opportunity as Facebook and Instagram parent Meta looks to diversify its revenue away from advertising.
MarketWatch
‘I’m afraid of human stupidity’: Why this top economist prefers U.S. tech and gold over bonds
A prominent economist doesn’t fear artificial intelligence, but fully embraces it in portfolios. He feels far differently about government debt.
MarketWatch